Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2012
04/24/2012US8163495 Method for isolating and/or identifying mesenchymal stem cells (MSC)
04/24/2012US8163470 Simulated 5-part differential leukocyte granules, the method for preparing the same and control products and calibrators comprising the same
04/24/2012US8163277 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants
04/24/2012US8163276 Systems and methods for isolating and using clinically safe adipose derived regenerative cells
04/24/2012US8163275 Multi-lineage progenitor cells
04/24/2012CA2656876C Method of cultivating cell or tissue
04/24/2012CA2583722C Nematode resistant transgenic plants
04/24/2012CA2532460C Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
04/24/2012CA2469209C Cultured cells from pancreatic islets
04/24/2012CA2466244C Methods and apparatus for production of a micro-organ
04/24/2012CA2350226C Protein expression vector and utilization thereof
04/24/2012CA2268812C Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
04/24/2012CA2239072C Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
04/19/2012WO2012051615A1 Novel vectors for production of glycosylated interferon
04/19/2012WO2012051599A2 Modulation neural pathways
04/19/2012WO2012051327A2 Method of dual-adapter recombination for efficient concatenation of multiple dna fragments in shuffled or specified arrangements
04/19/2012WO2012051317A1 Method for diagnosing and treating fibromyalgia
04/19/2012WO2012051210A2 Mesenchymal stem cells and related therapies
04/19/2012WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
04/19/2012WO2012051111A2 Human oncostatin m antibodies and methods of use
04/19/2012WO2012051105A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
04/19/2012WO2012050981A1 Device for high throughput investigations of cellular interactions
04/19/2012WO2012050627A2 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same
04/19/2012WO2012050269A1 Composition comprising mycobacterium tuberculosis rv0351 protein for promoting the maturation of dendritic cells
04/19/2012WO2012050193A1 Ebola virus liposome vaccine
04/19/2012WO2012050175A1 Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
04/19/2012WO2012050125A1 Method for producing monatin
04/19/2012WO2012049229A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof
04/19/2012WO2012049154A1 Quality determination of stem cells
04/19/2012WO2012048807A1 Methods for altering the reactivity of plant cell walls
04/19/2012WO2012048653A1 Long-life interferon fusion protein and use thereof
04/19/2012WO2012026687A3 Human blood-derived blood cell mass assay using cell coagulation, blood adult stem cells using same, method for expanding progenitor cells, and stem cells produced using the method
04/19/2012WO2012018484A3 Composition for preserving platelets and method of use thereof
04/19/2012WO2012015270A3 Permissive cell line to the porcine reproductive and respiratory syndrome virus
04/19/2012WO2012008733A3 Stem cells derived from primary placenta tissue and cellular therapeutic agent containing same
04/19/2012WO2011160128A3 Cardiomyocyte medium with dialyzed serum
04/19/2012WO2011159779A3 Percutaneously deliverable valves
04/19/2012WO2011159684A3 Generation of induced pluripotent stem cells from small volumes of peripheral blood
04/19/2012WO2011159359A4 Serum-free chemically defined cell culture medium
04/19/2012WO2011149529A3 Cell-based preparations for wound management
04/19/2012WO2011140397A3 Stem cell defined media for xeno-free and feeder free conditions and uses thereof
04/19/2012WO2011137414A3 Defense peptides againts fungal infection and method of their use
04/19/2012WO2011133902A3 Cell culture medium comprising small peptides
04/19/2012WO2011133432A9 Methods to detect and isolate cancer stem cells
04/19/2012WO2011130618A3 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
04/19/2012WO2011127214A3 Secretome profile-facilitated in vitro fertilization
04/19/2012US20120096600 Methods and means for obtaining plants with enhanced glyphosate tolerance
04/19/2012US20120096597 Polypeptides having Beta-glucosidase Activity and Polynucleotides Encoding Same
04/19/2012US20120096594 Soybean Transformation Method
04/19/2012US20120096593 Plants Having Enhanced Yield-Related Traits And/Or Enhanced Abiotic Stress Tolerance And A Method For Making The Same
04/19/2012US20120096592 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
04/19/2012US20120096590 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
04/19/2012US20120096589 Method for production of chrysanthemum plant having delphinidin-containing petals
04/19/2012US20120096588 Dgat genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
04/19/2012US20120096587 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
04/19/2012US20120096584 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
04/19/2012US20120096582 Rice transgenic event 17053 and methods of use thereof
04/19/2012US20120096580 Zantedeschia Variety 110224-64275
04/19/2012US20120096579 Zantedeschia Variety 110066-21104
04/19/2012US20120096578 Lettuce Variety Redglace
04/19/2012US20120096577 Inbred Broccoli Line BRM50-3906
04/19/2012US20120096576 Lettuce variety red bluff
04/19/2012US20120096575 Tomato hybrid ps02420487 and parent lines thereof
04/19/2012US20120096574 Tomato hybrid ps01819578
04/19/2012US20120096571 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095557 Dermal micro-organs, methods and apparatuses for producing and using the same
04/19/2012US20120095445 Methods and compositions for increasing trichogenic potency of dermal cells
04/19/2012US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same
04/19/2012US20120095193 Polypeptides and method of treatment
04/19/2012US20120095086 Protein tyrosine phosphatase mutations in cancers
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095079 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
04/19/2012US20120095076 Compositions and methods for inhibiting expression of huntingtin gene
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095058 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
04/19/2012US20120095032 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
04/19/2012US20120094980 Pyridyl inhibitors of hedgehog signalling
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094952 Polysialic Acid Derivatives, Methods of Production, and Uses in Enhancing Cancer Antigen Production and Targeting
04/19/2012US20120094947 Method for the selective therapy of disease
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094928 Compounds for enzyme inhibition
04/19/2012US20120094927 Therapy for mll-rearranged leukemia
04/19/2012US20120094925 Insulin-like growth factor binding protein 7 for treatment of cancer
04/19/2012US20120094924 Nucleic acid delivery compounds
04/19/2012US20120094908 Truncated activin type ii receptor and methods of use
04/19/2012US20120094906 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094870 Library of a Collection of Cells
04/19/2012US20120094865 Method for Stimulating Antigen-Specific T Cell Responses Using Accelerated Co-Cultured Dendritic Cells
04/19/2012US20120094384 Use of compounds for differentiation of cells
04/19/2012US20120094383 Methods for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes
04/19/2012US20120094382 Molecular delivery with nanowires
04/19/2012US20120094381 Methods of neural conversion of human embryonic stem cells
04/19/2012US20120094380 Human multipotent embryonic stem cell-like progenitor cells
04/19/2012US20120094379 Human endometriosis cell
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection